This Article

Citations


Creative Commons License
Except where otherwise noted, this work is licensed under Creative Commons Attribution-NonCommercial 4.0 International License.

Medicinal Plants Promise New Insights for Management of Diabetes


1 Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, IR Iran
*Corresponding author: Shirin Moradkhani, Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, IR Iran. Tel: +98-9123413411, E-mail: Shirin.moradkhani@yahoo.com.
Avicenna Journal of Medical Biochemistry. 4(2): e34245 , DOI: 10.17795/ajmb-34245
Article Type: Editorial; Received: Nov 16, 2015; Accepted: Nov 20, 2015; epub: Feb 21, 2016; collection: Sep 2016

Keywords: Diabetes Mellitus; Plants; Medicinal

Diabetes is a human-threatening disease can cause a high percentage of morbidity and mortality due to chronic complications (1, 2). The international diabetes federation estimated that, in 2014, 387 million people had diabetes; this number is expected to reach to 592 million by 2035 (3). Because of the increasing prevalence of this disease and the adverse effects of commonly used anti-diabetic drugs, it is vital to screen natural anti-diabetic remedies.


According to written documents, the use of phytoremedies dates back more than 5000 years. One-third to one-half of medicines currently in use was derived from herbs (4). For example Galega officinal is (Leguminosae) contains guanidine-type compounds that decrease blood sugar levels by reducing insulin resistance with toxicity. Galegin, an alkaloid isolated from a plant with less toxicity, was not effective in diabetes clinical trials. On the other hand, metformin, which is currently being used in medications that manage diabetes, has a biguanide structure (5).


Unlike traditional uses of phytomedicines, there are four major concerns that cause a lack of conviction in their usefulness in western medicine: controversial reports of efficacy in different studies (6); insufficient information about the exact mechanisms of effect (6) and safety (7); the absence of well-designed clinical trials (6) and concerns about kinetic and unwanted reactions in the co-administration of herbal medicines and conventional drugs (7). Crude herbal extracts are complex mixtures of many bioactive phytochemicals, so preparing standardized products seems to be vital (8).


Today, the treatment of diabetes has shifted from that of monotherapy to multiple therapies working in conjunction. Combination therapy is not capable of curing diabetes completely because the molecular etiology of diabetes has not been investigated. Insulin secretion and resistance, α-glycosidase activity, and in cretin production are the targets of present medicines. Botanicals are complex mixtures of compounds with multiple targets, which makes clinical trials complicated (9).


Considering the complicated etiology of diabetes, an herbal remedy with glucose regulation at several levels in different tissues could be effective (6). Despite the prevalent use of phytoremedies, the mechanism of action for only some of them has been investigated. Botanicals may exert their beneficial effects in diabetes management by reducing insulin resistance (licorice, dioscorea, blueberry, astragalus, cinnamon, fenugreek, and lychee); improving β-cell function (papaya, Silybium marianum, Gymnema sylvestre); regulating GLP-1 homeostasis (fructans, monounsaturated fatty acids); and regulating glucose absorption and α-glycosidase activity (safflower, kelp).


Some botanicals exert their antidiabetic effects via multiple mechanisms; examples of these botanicals are berberine, bitter melon, capsaicin/chili pepper, ginseng, turmeric, mate tea, ginger/gingerol, Chinese tea, soybean, Aloe vera, quercetin, resveratrol, and coffee (9). Thus, the scope of our investigation is finding the exact mechanism of function, molecular targeting, and standardization of herbal formulations besides using well-designed clinical trials (9).

Footnotes

Funding/Support: Vice Chancellor of Hamadan University of Medical Sciences

References


  • 1. Salehi I, Taheraslani Z, Moradkhani S. Hydro-alcoholic Extract of Commiphora mukul Gum Resin May Improve Cognitive Impairments in Diabetic Rats. Avicenna J Med Bio. 2015;2(2) [DOI]
  • 2. Pillai GK. Developing Novel Anti-Diabetic Drugs for Geriatric Population: Prospecting for Lead compounds among Botanical Formulations of Traditional Medicine. . Geriat Edu Med Sci. 2013;1(1):5-30.
  • 3. From Wikipedia. Diabetes mellitus. USA: Wikipedia; 2015; [cited Nov]; Available from: https://en.wikipedia.org/wiki/...
  • 4. Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med. 2008;23(6):854-9. [DOI] [PubMed]
  • 5. From Wikipedia. Galega officinalis. USA: Wikipedia; 2015; Available from: https://en.wikipedia.org/wiki/...
  • 6. Cefalu WT, Stephens JM, Ribnicky DM. Herbal Medicine: Biomolecular and Clinical Aspects. 2 ed. 1. California: Tylor and Francis; 2011. p. 405-19.
  • 7. Moreira D, Teixeira S, Monteiro M, De-Oliveira A, Paumgartten FJR. Traditional use and safety of herbal medicines1. Brasil Farmac J. 2014;24(2):248-57. [DOI]
  • 8. Yong EL, Wong SP, Shen P, Gong YH, Li J, Hong Y. Standardization and evaluation of botanical mixtures: lessons from a traditional Chinese herb, Epimedium, with oestrogenic properties. Novartis Found Symp. 2007;282:173-88. discussion 188-91, 212-8 [PubMed]
  • 9. Chang CL, Lin Y, Bartolome AP, Chen YC, Chiu SC, Yang WC. Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid Based Complement Alternat Med. 2013;2013:378657. [DOI] [PubMed]